CDC now tracking BN.1, the latest new COVID variant on the rise
The strain has climbed to make up 4.3% of new COVID-19 cases nationwide.
Stay updated with breaking news from Astrazeneca Evusheld. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The strain has climbed to make up 4.3% of new COVID-19 cases nationwide.
Emerging Omicron subvariants XBB, BQ.1, and BQ1.1 are likely resistant to some of the top drugs used to treat COVID-19 infections, experts warn.
Emerging Omicron subvariants XBB, BQ.1, and BQ1.1 are likely resistant to some of the top drugs used to treat COVID-19 infections, experts warn.
Emerging Omicron subvariants XBB, BQ.1, and BQ1.1 are likely resistant to some of the top drugs used to treat COVID-19 infections, experts warn.
Emerging Omicron subvariants XBB, BQ.1, and BQ1.1 are likely resistant to some of the top drugs used to treat COVID-19 infections, experts warn.